Evidence map›Paper›PMID 41300308›Full record

ArticleBiology2025

Systematic Analysis of the

Bo Liu, Lingyang Kong, Junbai Ma, Shan Jiang, Lengleng Ma, Jiao Xu, Weichao Ren, Wei Ma

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bo LiuCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Lingyang KongCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Junbai MaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.ORCID 0009-0008-4645-6069
Shan JiangCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Lengleng MaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Jiao XuCollege of Jiamusi, Heilongjiang University of Chinese Medicine, Jiamusi 154000, China.
Weichao RenCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Wei MaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150040, China.

Funding

Heilongjiang Province "double first-class" discipline collaborative innovation achievement project:Quality optimization and deep processing of characteristic Chinese medicinal materials in the lower cold region of great health industry No. LJGXCG2023-058Heilongjiang Touyan Innovation Team Program [2019] No. 5National Key Research and development Project, research and demonstration of collection, screening and breeding technology of ginseng and other genuine medicinal materials No.2021YFD1600901
6 · The paper itself

Abstract

Caffeoyl CoA O-methyltransferase (

Indexed as

CCoAOMT genechemical compositionevolutionary analysisIsatis indigoticaqRT-PCRyeast monoculture

Identifiers

PMID41300308
PMCPMC12649902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.